Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13232 |
TyK2-IN-2
|
PDE | Metabolism |
TyK2-IN-2 is a selective inhibitor of TYK2 (IC50s: 7 nM, 0.1 μM, and 0.05 μM for TYK2 JH2, IL-23, and IFNα). | |||
T13237L |
Ropsacitinib
Tyk2-IN-8,PF-06826647 |
Tyrosine Kinases | Tyrosine Kinase/Adaptors |
Ropsacitinib (PF-06826647) 是一种选择性TYK2抑制剂。Ropsacitinib 与Tyk2催化活性JH1结构域结合(IC50:17nM)。 | |||
T13234 |
Tyk2-IN-5
|
Others | Others |
Tyk2-IN-5 is a selective and orally active inhibitor of Tyk2 JH2 (Ki: 0.086 nM for Tyk2 JH2; IC50: 25 nM for IFNα). | |||
T13237 |
Tyk2-IN-9
|
Others | Others |
Tyk2-IN-9 (化合物26),作为一种高选择性Tyk-2抑制剂,展现出对TYK2-JH2的IC50为0.076 nM,及对JAK1-JH2的IC50为1.8 nM,显示其在炎症或自身免疫性疾病研究中的应用前景。 | |||
T13233 |
Tyk2-IN-3
|
Tyrosine Kinases | Tyrosine Kinase/Adaptors |
Tyk2-IN-3 is an inhibitor of Tyk2 pseudokinase (IC50: 485 nM). | |||
T13235 |
Tyk2-IN-7
|
Others | Others |
Tyk2-IN-7 is an inhibitor of TYK2 JH2, binds to the TYK2 JH2 domain (IC50: 0.00053 μM; Ki.app: 0.00007 μM). | |||
T22416 |
RO495
CS-2667 |
Tyrosine Kinases; JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
RO495 (CS-2667) 是一种有效的非受体酪氨酸蛋白激酶2抑制剂。 | |||
T63146 |
JAK2/TYK2-IN-1
|
||
JAK2/TYK2-IN-2 是一种有效的、选择性的 TYK2 (IC50: 9 nM) 和 JAK2 (IC50: 157 nM) 抑制剂,具有抗炎作用。 | |||
T62451 |
TYK2-IN-12
|
||
TYK2-IN-12 (compound 30) 是一种选择性的、口服具有活力的 TYK2 (酪氨酸激酶 2) 抑制剂 (Ki: 0.51 nM)。TYK2-IN-12 对 IL-12 诱导的人和小鼠全血中 IFNγ 具有抑制作用,他们的 IC50 值分别为 2.7 和 7.0 μM。TYK2-IN-12 能够用于研究银屑病。 | |||
T61658 |
TYK2-IN-11
|
||
TYK2-IN-11 (Compound 5B) is a potent and selective inhibitor of Tyk-2, providing inhibition to TYK2-JH2 and JAK1-JH2 with IC50 values of 0.016 nM and 0.31 nM, respectively. This compound demonstrates potential for advancing research in the area of inflammatory and autoimmune diseases [1]. | |||
T83218 | ABBV-712 | JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
ABBV-712为选择性酪氨酸激酶 2 (TYK2) 抑制剂,IC50值为0.195 μM,关键作用于自身免疫性疾病。 | |||
T70394 | Deucravacitinib HCl | ||
Deucravacitinib HCl is a Highly Potent and Selective Allosteric Inhibitor of TYK2. BMS-986165 Blocks Il-12, IL-23 and type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Inflammatory Bowel Disease. MS-986165 potently binds to the Tyk2 pseudokinase domain (Ki = 0.02 nM), and is highly selective against a panel of 265 kinases and pseudokinases. The compound potently inhibited IL-23-, IL-12-, and Type I interferon-driven cellular signaling and transcriptional resp... | |||
T79235 |
JAK-IN-30
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK-IN-30(化合物31)是一种具有水溶性的JAK抑制剂,对JAK2、JAK1、JAK3及TYK2的IC50值分别为2、15、18及2 nM。该化合物作为研究干眼症(DED)的潜在药物而备受关注。 |